This website is intended for US Healthcare Professionals.

PROTAC Protein Degraders

A novel approach to targeted protein degradation—these uniquely designed molecules harness the ubiquitin-proteasome system’s natural degradation process to eliminate disease causing proteins.

Mechanism of Action

See how PROTACs work.

Innovative Science

Download a PROTAC science infographic.

Targeted Protein Degradation

PROTACs harness the body’s natural protein disposal system to target disease-causing proteins. 

PROTAC Molecular Design

PROTACs are designed to target specific proteins and act iteratively.

PROTAC Potential Applications

Explore targeted protein degradation with PROTACs. 

Arvinas is a clinical-stage biotechnology company leading the way in the development of targeted protein degradation therapeutics.

Arvinas Oncology Medical

This website is intended for US Healthcare Professionals. It includes educational resources related to Arvinas’ investigational agents, research, and therapeutic areas of interest.

By selecting continue below, you acknowledge the information above and certify that you are a US Healthcare Professional (HCP).

If you are a member of the public who would like to learn more about Arvinas’ investigational drugs click below to be directed to Arvinas.com.